Chemed Corporation

CHE Healthcare Medical Care Facilities

Chemed Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 4.06% from fiscal 2024.

Revenue
+10.6%
EPS
+23.1%
Free cash flow
−45.3%

Quarter to September 2026, against a year earlier

525.70 8.07 −1.51%
Market cap
$7.0B
P/E
25.5×
Fwd P/E
24.0×
Dividend yield
0.47%
F-score
6/9
Altman Z
11.69
Beneish M
−2.76
Dividend safety
100/100
Older periods Dec '25 Mar '26 Jun '26 Sep '26
Piotroski F-Score

+8 more TTM periods

6 5 5 7
ROE
25.28% 25.60% 27.11% 29.14%
ROA
16.54% 15.93% 16.68% 16.90%
ROIC
23.36% 22.23% 23.46% 22.10%
Return on Tangible Assets
119.94% 161.98% 152.87% 112.17%
Average Days of Receivables
26.34 30.96 26.53 34.96
Free Cash Flow per Share
22.92 27.91 24.91 22.73
Free Cash Flow
330.05 381.71 328.12 296.76
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026